Vimentin expression is retained in erythroid cells differentiated from human iPSC and ESC and indicates dysregulation in these cells early in differentiation.
Kongtana TrakarnsangaDaniel FergusonDeborah E DanielsRebecca E GriffithsMarieangela C WilsonKathryn E MordueAbi GartnerTatyana N AndrienkoAnnabel CalvertAlison CondieAngela McCahillJoanne C MountfordAshley M ToyeDavid J AnsteeJan FraynePublished in: Stem cell research & therapy (2019)
As both embryonic and adult erythroid cells loose vimentin and enucleate, retention of vimentin by iPSC and ESC erythroid cells indicates an intrinsic defect. By analogy with avian erythrocytes which naturally retain vimentin and remain nucleated, retention in iPSC- and ESC-derived erythroid cells may impede enucleation. Our data also provide the first evidence that dysregulation of processes in these cells occurs from the early stages of differentiation, facilitating targeting of future studies.